Health Care Sector
734 health care stocks ranked by market capitalization, page 5 of 15. Updated October 7, 2026.
Today
-0.36%Health Care stocks ranked 201–250
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 201 | EBS | Emergent BioSolutions Inc. | 7.07 | +1.73% | 1.23M | $362.50M |
| 202 | ENTA | Enanta Pharmaceuticals Inc. | 12.37 | +1.64% | 191.66K | $360.28M |
| 203 | VMD | Viemed Healthcare Inc. | 9.37 | +0.43% | 366.63K | $356.89M |
| 204 | CV | CapsoVision Inc. | 6.54 | +0.62% | 104.53K | $348.00M |
| 205 | CCCC | C4 Therapeutics Inc. | 2.82 | -2.08% | 2.27M | $346.93M |
| 206 | RLMD | Relmada Therapeutics Inc. | 3.25 | -0.91% | 1.50M | $346.68M |
| 207 | ARTV | Artiva Biotherapeutics Inc. | 7.00 | -3.71% | 324.47K | $342.23M |
| 208 | AGEN | Agenus Inc. | 7.57 | +1.07% | 1.15M | $341.88M |
| 209 | OBIO | Orchestra BioMed Holdings Inc. | 5.66 | -3.08% | 241.22K | $340.19M |
| 210 | OCGN | Ocugen Inc. | 1.00 | -3.85% | 5.20M | $339.11M |
| 211 | EMBC | Embecta Corp. | 5.91 | -0.67% | 994.13K | $334.86M |
| 212 | CABA | Cabaletta Bio Inc. | 1.97 | -2.48% | 2.14M | $334.00M |
| 213 | SCTX | Scribe Therapeutics Inc. | 17.57 | +7.59% | 420.24K | $332.63M |
| 214 | CYPH | Cypherpunk Technologies Inc. | 3.05 | -6.44% | 8.04M | $328.68M |
| 215 | CLPT | ClearPoint Neuro Inc. | 10.66 | -3.18% | 490.13K | $325.18M |
| 216 | SMTI | Sanara MedTech Inc. | 35.05 | +0.14% | 136.15K | $322.04M |
| 217 | BNTC | Benitec Biopharma Inc. | 8.99 | -0.11% | 190.05K | $313.60M |
| 218 | SNDL | SNDL Inc. | 1.25 | +1.63% | 1.25M | $307.65M |
| 219 | PRLD | Prelude Therapeutics Incorporated | 3.83 | +0.52% | 454.55K | $305.65M |
| 220 | INDP | Indaptus Therapeutics Inc. | 2.26 | -12.74% | 589.09K | $301.13M |
| 221 | SRZN | Surrozen Inc. | 25.15 | -4.65% | 374.21K | $295.54M |
| 222 | ABEO | Abeona Therapeutics Inc. | 5.08 | +1.40% | 736.72K | $290.49M |
| 223 | BIOA | BioAge Labs Inc. | 6.26 | -0.48% | 799.45K | $287.31M |
| 224 | LRMR | Larimar Therapeutics Inc. | 2.75 | -1.08% | 717.37K | $285.68M |
| 225 | MOBI | Mobia Medical Inc. | 8.51 | -3.30% | 115.07K | $283.31M |
| 226 | ACB | Aurora Cannabis Inc. | 4.46 | -2.83% | 1.37M | $282.36M |
| 227 | CATX | Perspective Therapeutics Inc. | 2.46 | +4.24% | 1.29M | $280.81M |
| 228 | FULC | Fulcrum Therapeutics Inc. | 3.67 | -0.54% | 1.04M | $280.01M |
| 229 | BDSX | Biodesix Inc. | 26.42 | -5.51% | 57.53K | $278.76M |
| 230 | XFOR | X4 Pharmaceuticals Inc. | 2.81 | +1.44% | 434.33K | $278.60M |
| 231 | RCKT | Rocket Pharmaceuticals Inc. | 2.54 | +2.22% | 2.81M | $278.28M |
| 232 | BBOT | BridgeBio Oncology Therapeutics Inc. | 3.44 | -1.71% | 321.31K | $275.80M |
| 233 | VNDA | Vanda Pharmaceuticals Inc. | 4.56 | +0.89% | 757.78K | $275.71M |
| 234 | LXEO | Lexeo Therapeutics Inc. | 3.31 | +0.30% | 1.20M | $271.71M |
| 235 | USNA | USANA Health Sciences Inc. | 14.67 | -1.08% | 135.96K | $271.05M |
| 236 | IKT | Inhibikase Therapeutics Inc. | 1.94 | -2.02% | 444.05K | $270.70M |
| 237 | INFU | InfuSystems Holdings Inc. | 13.33 | +0.45% | 113.85K | $265.50M |
| 238 | SABS | SAB Biotherapeutics Inc. | 2.88 | -1.71% | 679.31K | $262.04M |
| 239 | TLSI | TriSalus Life Sciences Inc. | 4.25 | -0.47% | 185.28K | $261.69M |
| 240 | ANIK | Anika Therapeutics Inc. | 19.53 | +2.14% | 182.65K | $261.37M |
| 241 | BCYC | Bicycle Therapeutics plc ADR | 3.73 | -1.58% | 472.23K | $261.07M |
| 242 | PALI | Palisade Bio Inc. | 1.48 | -0.67% | 825.23K | $257.92M |
| 243 | FATE | Fate Therapeutics Inc. | 2.15 | -6.11% | 861.15K | $257.61M |
| 244 | OSUR | OraSure Technologies Inc. | 3.73 | -1.06% | 435.06K | $257.25M |
| 245 | ACIU | AC Immune SA | 2.57 | +1.98% | 125.05K | $255.53M |
| 246 | AMRN | Amarin Corporation plc | 12.02 | -0.41% | 74.94K | $253.90M |
| 247 | TMCI | Treace Medical Concepts Inc. | 3.89 | -2.75% | 250.34K | $252.98M |
| 248 | UPB | Upstream Bio Inc. | 4.61 | +0.44% | 908.40K | $252.49M |
| 249 | ZNTL | Zentalis Pharmaceuticals Inc. | 2.55 | -4.49% | 819.97K | $250.21M |
| 250 | IMRX | Immuneering Corporation Class A | 3.86 | +0.78% | 747.56K | $249.73M |
Prices as of Oct 7, 5:11 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer